Know Cancer

or
forgot password

The Use of Adrenalectomy in Patients With Solitary Adrenal Gland Metastases


N/A
N/A
N/A
Not Enrolling
Both
Adrenal Gland Metastases, Adrenalectomy

Thank you

Trial Information

The Use of Adrenalectomy in Patients With Solitary Adrenal Gland Metastases


Inclusion Criteria:



- Metastatic disease to the adrenal gland

Exclusion Criteria:

- Primary adrenal neoplasm

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Retrospective

Outcome Measure:

Adrenalectomy improves overall survival in patients with solitary metastasis

Outcome Description:

Survival data compared to historic controls

Outcome Time Frame:

25 years

Safety Issue:

No

Principal Investigator

Melanie L Richards, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Mayo Clinic

Authority:

United States: Institutional Review Board

Study ID:

09-007747

NCT ID:

NCT01135238

Start Date:

November 2009

Completion Date:

November 2010

Related Keywords:

  • Adrenal Gland Metastases
  • Adrenalectomy
  • adrenalectomy
  • metastasis
  • morbidity
  • mortality
  • survival
  • Neoplasm Metastasis
  • Neoplasms, Second Primary
  • Adrenal Gland Neoplasms

Name

Location